Now in its 16th year, the NJBIZ Healthcare Heroes program was created to recognize excellence, promote innovation and commend the efforts of those making a significant impact on the industry in New Jersey. But you need to hurry to enter your nomination, which is due June 5.
An agreement with a Euroimmun subsidiary based in Mountain Lakes allows the company to offer the kit – which can help patients determine whether their current vaccinations or boosters are providing adequate protection – in the U.S. and Canada.
The Camden provider said it learned of the unusual activity in December and immediately launched an investigation — assisted by independent cybersecurity experts — to determine what had happened, and whether personal or protected health information had been accessed or acquired without authorization.
The Parsippany pharmaceutical company agreed to pay $75 million over 15 years in addition to $8 million in attorneys’ fees and costs incurred during the trial. It will also provide the state its opioid-overdose treatment, valued at $27 million, over 10 years.
In preparation for the commercialization of its two late-stage products, the biopharmaceutical firm plans to form NewCo to focus on developing and commercializing its treatment for cutaneous T-cell lymphoma.
Drayton Wise joined Insmed Inc. in 2014 and most recently served as senior vice president, head of U.S., and general manager of Arikayce, the company's FDA-approved lung disease drug.
The moves expand the Flanders supplier's reach further across the Garden State as well as into eastern and central Pennsylvania and upstate New York and Connecticut.
Dr. Peter Shin, who has served as section chief of hospital medicine since 2015, succeeds Dr. Alexandra Gottdiener, who was named to the role in 2009.
Dr. Suja Mathew will focus on three key areas: optimizing patient access to the system's full network of care, elevating research and academic programs, and continuing AHS's commitment to high-quality care.
The funding will go toward 28 projects to modernize systems for nearly 6 million state residents.
"Having a vaccine platform such as this available has the potential to accelerate worldwide vaccination campaigns addressing future health emergencies, including other global pandemics as seen with COVID-19,” said research collaborator Axel Lehrer, an associate professor at the University of Hawaiʽi at Mānoa.
The president and CEO of the Health Care Institute of New Jersey talks about where growth in the life sciences industry will come from in the near future, government moves to reign in health care costs and the business climate in the state.